Search research articles
Contact Us
Filters
Showing results (41-50 of 269) with videos related to
Page
of 27
Sort By:
European Heart Journal
|
January 1, 2023
The year in cardiovascular medicine 2022: the top 10 papers in cardio-oncology
Joerg Herrmann, Teresa Lpez-Fernndez, Alexander R Lyon
Future Oncology (London, England)
|
July 23, 2015
Should vascular effects of newer treatments be addressed more completely?
Eric H Yang, Karol E Watson, Joerg Herrmann
Current Cardiology Reports
|
March 4, 2014
Assessing clinical impact of myocardial perfusion studies: ischemia or other prognostic indicators?
Todd D Miller, John Wells Askew, Joerg Herrmann
European Heart Journal
|
April 9, 2024
The year in cardiovascular medicine 2023: the top 10 papers in cardio-oncology
Joerg Herrmann, Teresa López-Fernández, Alexander R Lyon
JACC. Basic to Translational Science
|
July 29, 2024
Costimulatory and Coinhibitory Immune Checkpoints in Atherosclerosis: Therapeutic Targets in Atherosclerosis?
Katrin Nitz, Joerg Herrmann, Amir Lerman, et al.
Mayo Clinic Proceedings
|
December 3, 2014
New-onset heart failure in association with severe hypertension during trastuzumab therapy
Joerg Herrmann, Sandra M Herrmann, Tufia C Haddad
Current Oncology Reports
|
March 12, 2018
Exercise Training and Cardiovascular Health in Cancer Patients
Ray W Squires, Adam M Shultz, Joerg Herrmann
European Heart Journal
|
January 28, 2025
The year in cardiovascular medicine 2024: the top 10 papers in cardio-oncology
Joerg Herrmann, Teresa López-Fernández, Alexander R Lyon
Journal of Cardiovascular Translational Research
|
April 8, 2020
Precision Cardio-Oncology: a Systems-Based Perspective on Cardiotoxicity of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors
Sherry-Ann Brown, Jordan C Ray, Joerg Herrmann
European Heart Journal
|
January 2, 2022
Year in cardiovascular medicine: cardio-oncology 2020-21
Joerg Herrmann, Teresa López-Fernández, Alexander R Lyon
Page
of 27
Search research articles
Search
Showing results (41-50 of 269) with videos related to
Sort By:
Page
of 27
European Heart Journal
|
January 1, 2023
The year in cardiovascular medicine 2022: the top 10 papers in cardio-oncology
Joerg Herrmann, Teresa Lpez-Fernndez, Alexander R Lyon
Future Oncology (London, England)
|
July 23, 2015
Should vascular effects of newer treatments be addressed more completely?
Eric H Yang, Karol E Watson, Joerg Herrmann
Current Cardiology Reports
|
March 4, 2014
Assessing clinical impact of myocardial perfusion studies: ischemia or other prognostic indicators?
Todd D Miller, John Wells Askew, Joerg Herrmann
European Heart Journal
|
April 9, 2024
The year in cardiovascular medicine 2023: the top 10 papers in cardio-oncology
Joerg Herrmann, Teresa López-Fernández, Alexander R Lyon
JACC. Basic to Translational Science
|
July 29, 2024
Costimulatory and Coinhibitory Immune Checkpoints in Atherosclerosis: Therapeutic Targets in Atherosclerosis?
Katrin Nitz, Joerg Herrmann, Amir Lerman, et al.
Mayo Clinic Proceedings
|
December 3, 2014
New-onset heart failure in association with severe hypertension during trastuzumab therapy
Joerg Herrmann, Sandra M Herrmann, Tufia C Haddad
Current Oncology Reports
|
March 12, 2018
Exercise Training and Cardiovascular Health in Cancer Patients
Ray W Squires, Adam M Shultz, Joerg Herrmann
European Heart Journal
|
January 28, 2025
The year in cardiovascular medicine 2024: the top 10 papers in cardio-oncology
Joerg Herrmann, Teresa López-Fernández, Alexander R Lyon
Journal of Cardiovascular Translational Research
|
April 8, 2020
Precision Cardio-Oncology: a Systems-Based Perspective on Cardiotoxicity of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors
Sherry-Ann Brown, Jordan C Ray, Joerg Herrmann
European Heart Journal
|
January 2, 2022
Year in cardiovascular medicine: cardio-oncology 2020-21
Joerg Herrmann, Teresa López-Fernández, Alexander R Lyon
Page
of 27